Form Type: 4

SEC EDGAR Link
Accession Number:0000874015-19-000108
Date:2019-07-01
Issuer: IONIS PHARMACEUTICALS INC (IONS)
Original Submission Date:

Reporting Person:

HERMAN JOAN E
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT CARLSBAD, CA 92010

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2019-07-01 deemed execution date A 7,110 (a) common stock 7,110 $0.00 7,110 direct
DIRECTOR STOCK OPTION (RIGHT TO BUY) 64.8 2019-07-01 deemed execution date A 16,000 (a) 2020-07-01 2029-06-30 common stock 16,000 $64.80 16,000 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of ionis common stock, or its equivalent cash value.
f2 grant of july 1, 2019 to reporting person of restricted stock unit award under the amended and restated ionis pharmaceuticals, inc. 2002 non-employee directors' stock option plan. restricted stock units vest in four equal annual installments, the first installment vesting on july 1, 2020. upon vesting, the restricted stock units will be paid out in whole shares of ionis common stock or cash as may be determined by the company. the rsu shall be fully vested on july 1, 2023. the rsu is vested as to 0 shares on july 1, 2019.
f3 grant of july 1, 2019 to reporting person of stock options under the amended and restated ionis pharmaceuticals, inc. 2002 non-employee directors' stock option plan. the option vests and becomes exercisable in four equal annual installments, the first installment vesting on july 1, 2020. the option shall be fully vested and exercisable on july 1, 2023. the option is exercisable to 0 shares on july 1, 2019.
WhaleWisdom Logo

Elevate your investments